Stealth BioTherapeutics Corp MITO

Full chart Compare
Set alert

Price alert · MITO

All alert types
0.32 0.00 (+0.00%)

At closeNov 15, 2022, 4:00 PM EST

0.32 Day range 0.33

52-week range unavailable

Valuation

P/E -0.7×
FY 2016: -4.0×FY 2017: -2.3×FY 2018: -2.5×FY 2019: -1.4×FY 2020: -1.2×FY 2021: -0.7×
FY 2016 5y median -1.4× FY 2021
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 4.8×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021
P/B -0.8×
FY 2016: -1.2×FY 2017: -0.6×FY 2018: -0.6×FY 2019: 5.9×FY 2020: -6.7×FY 2021: -0.8×
FY 2016 5y median -0.6× FY 2021
P/FCF -0.9×
FY 2016: -4.5×FY 2017: -2.7×FY 2018: -3.4×FY 2019: -2.1×FY 2020: -1.3×FY 2021: -0.9×
FY 2016 5y median -2.1× FY 2021
EV/EBITDA -0.1×
FY 2016: -3.8×FY 2017: -3.1×FY 2018: -4.7×FY 2019: -1.0×FY 2020: -0.8×FY 2021: -0.1×
FY 2016 5y median -1.0× FY 2021
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 3.2×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021
FCF Yield -117.1%
FY 2016: -22.4%FY 2017: -37.0%FY 2018: -29.7%FY 2019: -47.1%FY 2020: -77.3%FY 2021: -117.1%
FY 2016 5y median -47.1% FY 2021

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -217.3%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -340.2%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
ROE 118.7%
FY 2016: 29.1%FY 2017: 28.5%FY 2018: 25.0%FY 2019: -415.4%FY 2020: 554.0%FY 2021: 118.7%
FY 2016 5y median 28.5% FY 2021
ROIC -130.2%
FY 2016: -3999.8%FY 2017: 457.1%FY 2018: 452.5%FY 2019: -136.8%FY 2020: -204.5%FY 2021: -130.2%
FY 2016 5y median -130.2% FY 2021
ROA -107.1%
FY 2016: -458.3%FY 2017: -1158.8%FY 2018: -623.0%FY 2019: -136.0%FY 2020: -160.3%FY 2021: -107.1%
FY 2016 5y median -160.3% FY 2021

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -100.0%FY 2021: 0.0%
FY 2016 FY 2021
Operating Income -5.4%
FY 2016: 0.0%FY 2017: -28.9%FY 2018: 5.6%FY 2019: 39.1%FY 2020: -6.2%FY 2021: -5.4%
FY 2016 FY 2021
EPS (diluted) 6.5%
FY 2016: 0.0%FY 2017: -74.6%FY 2018: 9.2%FY 2019: 51.7%FY 2020: 45.9%FY 2021: 6.5%
FY 2016 FY 2021
Free Cash Flow 15.9%
FY 2016: 0.0%FY 2017: -28.9%FY 2018: -3.0%FY 2019: 33.3%FY 2020: -11.3%FY 2021: 15.9%
FY 2016 FY 2021

Financial Health

Current Ratio 4.6×
FY 2016: 1.0×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 1.5×FY 2020: 1.7×FY 2021: 4.6×
FY 2016 5y median 1.5× FY 2021
Quick Ratio 4.6×
FY 2016: 1.0×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 1.5×FY 2020: 1.7×FY 2021: 4.6×
FY 2016 5y median 1.5× FY 2021
Debt / Equity -0.3×
FY 2016: 0.0×FY 2017: -0.2×FY 2018: -0.3×FY 2019: 0.9×FY 2020: -0.9×FY 2021: -0.3×
FY 2016 5y median -0.3× FY 2021
Net Debt / EBITDA 0.7×
FY 2016: 0.2×FY 2017: -0.8×FY 2018: -1.5×FY 2019: 0.5×FY 2020: 0.4×FY 2021: 0.7×
FY 2016 5y median 0.4× FY 2021
Interest Coverage -41.3×
FY 2016: 0.0×FY 2017: -24.3×FY 2018: -3.5×FY 2019: -6.9×FY 2020: -26.9×FY 2021: -41.3×
FY 2016 5y median -24.3× FY 2021

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31